{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:55:21Z","timestamp":1791654921846,"version":"4.3.4"},"reference-count":96,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Over the past decade, the global burden of depression has increased and remains higher in women than in men. Emerging evidence suggests that low testosterone is linked to depressive symptoms in both sexes, raising important questions about its causal role and potential as a therapeutic target.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To provide a narrative review of the literature on the relationship between testosterone and depression across both sexes, examine underlying neurobiological mechanisms, and assess the efficacy and risks of testosterone replacement therapy (TRT) as a treatment for depressive symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a narrative review of PubMed, Medline, and Google Scholar for articles published between 1980 and 2024. Eligible sources included primary research articles, systematic reviews, meta-analyses, and narrative reviews that examined the relationship between testosterone levels, depression, and the effects of TRT on mood regulation. Search terms include low testosterone, hypogonadism, depression, mood disorders, androgen deficiency, TRT, neurotransmitters, and mental health.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Low testosterone is associated with depressive symptoms, particularly in hypogonadal men. Testosterone modulates serotonergic, dopaminergic, and GABAergic systems and acts on brain regions involved in mood regulation, including the prefrontal cortex, amygdala, and hippocampus. TRT improves mood, energy, and libido in hypogonadal men, though evidence in eugonadal men and women is mixed. Ethnic and genetic factors, such as androgen receptor Cytosine, Adenine, Guanine (CAG) repeat length, may influence susceptibility and treatment response. Risks of TRT include erythrocytosis, prostate-specific antigen elevation, cardiovascular events, and metabolic changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Testosterone may play a significant role in mood regulation, and its deficiency may contribute to depressive symptoms. TRT is a promising treatment option for select patients, though it must be personalized and closely monitored to balance therapeutic benefits with potential risks.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/sxmrev\/qeag024","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T11:45:28Z","timestamp":1778067928000},"source":"Crossref","is-referenced-by-count":1,"title":["The interplay between testosterone and depression: bridging research, clinical applications, and health: a narrative review"],"prefix":"10.1093","volume":"14","author":[{"given":"Megan C","family":"Abadom","sequence":"first","affiliation":[{"name":"University of Texas Medical Branch\u2014John Sealy School of Medicine , Galveston, TX 77554 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Nyong","sequence":"additional","affiliation":[{"name":"University of Texas Medical Branch\u2014John Sealy School of Medicine , Galveston, TX 77554 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz S","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Scott Department of Urology\u2014Baylor College of Medicine , Houston, TX 77030 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3053-5828","authenticated-orcid":false,"given":"Gal","family":"Saffati","sequence":"additional","affiliation":[{"name":"Scott Department of Urology\u2014Baylor College of Medicine , Houston, TX 77030 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Parikh","sequence":"additional","affiliation":[{"name":"Scott Department of Urology\u2014Baylor College of Medicine , Houston, TX 77030 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Khera","sequence":"additional","affiliation":[{"name":"Scott Department of Urology\u2014Baylor College of Medicine , Houston, TX 77030 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"2026050608273664900_ref1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jpsychires.2019.08.002","article-title":"Changes in the global burden of depression from 1990 to 2017: findings from the Global Burden of Disease study","volume":"126","author":"Liu","year":"2020","journal-title":"J Psychiatr Res"},{"issue":"Suppl 6","key":"2026050608273664900_ref2","first-page":"4","article-title":"History and evolution of the monoamine hypothesis of depression","volume":"61","author":"Hirschfeld","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"2026050608273664900_ref3","doi-asserted-by":"publisher","first-page":"100044","DOI":"10.1016\/j.cpnec.2021.100044","article-title":"Testosterone and specific symptoms of depression: evidence from NHANES 2011\u20132016","volume":"6","author":"M\u00e4\u00e4tt\u00e4nen","year":"2021","journal-title":"Compr Psychoneuroendocrinol"},{"issue":"2","key":"2026050608273664900_ref4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1210\/jcem.84.2.5495","article-title":"Bioavailable testosterone and depressed mood in older men: the rancho Bernardo study","volume":"84","author":"Barrett-Connor","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026050608273664900_ref5","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0006-3223(01)01148-9","article-title":"Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged men","volume":"50","author":"Seidman","year":"2001","journal-title":"Biol Psychiatry"},{"issue":"3 Suppl","key":"2026050608273664900_ref6","first-page":"51","article-title":"Androgens and fertility","volume":"28","author":"Lombardo","year":"2005","journal-title":"J Endocrinol Investig"},{"issue":"2","key":"2026050608273664900_ref7","doi-asserted-by":"publisher","first-page":"e78785","DOI":"10.7759\/cureus.78785","article-title":"Benefits of testosterone hormone in the human body: a systematic review","volume":"17","author":"Rojas-Zambrano","year":"2025","journal-title":"Cureus"},{"issue":"3","key":"2026050608273664900_ref8","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/andr.12169","article-title":"Cross-sectional association between physical activity and serum testosterone levels in US men: results from NHANES 1999-2004","volume":"4","author":"Steeves","year":"2016","journal-title":"Andrology."},{"issue":"6","key":"2026050608273664900_ref9","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1111\/andr.12867","article-title":"Testosterone, mood, behaviour and quality of life","volume":"8","author":"Zitzmann","year":"2020","journal-title":"Andrology."},{"issue":"10","key":"2026050608273664900_ref10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S2213-8587(24)00199-2","article-title":"Male hypogonadism: pathogenesis, diagnosis, and management","volume":"12","author":"De Silva","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2026050608273664900_ref11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ecl.2021.11.001","article-title":"Diagnosis and evaluation of hypogonadism","volume":"51","author":"Matsumoto","year":"2022","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"2","key":"2026050608273664900_ref12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/wps.20050","article-title":"The DSM-5: classification and criteria changes","volume":"12","author":"Regier","year":"2013","journal-title":"World Psychiatry"},{"issue":"9","key":"2026050608273664900_ref13","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.psyneuen.2006.06.005","article-title":"Calculated bioavailable testosterone levels and depression in middle-aged men","volume":"31","author":"Mcintyre","year":"2006","journal-title":"Psychoneuroendocrinology."},{"issue":"4","key":"2026050608273664900_ref14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jagp.2016.12.014","article-title":"Plasma testosterone and the course of major depressive disorder in older men and women","volume":"25","author":"Giltay","year":"2017","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"2026050608273664900_ref15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/biolre\/ioy059","article-title":"Leydig cells: formation, function, and regulation","volume":"99","author":"Zirkin","year":"2018","journal-title":"Biol Reprod"},{"issue":"Suppl 4","key":"2026050608273664900_ref16","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/s0015-0282(02)02985-0","article-title":"Androgen production in women","volume":"77","author":"Burger","year":"2002","journal-title":"Fertil Steril"},{"issue":"2","key":"2026050608273664900_ref17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1210\/jcem-62-2-331","article-title":"Contribution of the adrenal gland to the production of androstenedione and testosterone during the first two years of life","volume":"62","author":"Bidlingmaier","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"2026050608273664900_ref18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fendo.2018.00279","article-title":"Androgen regulation of the mesocorticolimbic system and executive function","volume":"9","author":"Tobiansky","year":"2018","journal-title":"Front Endocrinol"},{"key":"2026050608273664900_ref19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fnins.2015.00012","article-title":"On the effects of testosterone on brain behavioral functions","volume":"9","author":"Celec","year":"2015","journal-title":"Front Neurosci"},{"issue":"3","key":"2026050608273664900_ref20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.yhbeh.2014.01.001","article-title":"New knockout model confirms a role for androgen receptors in regulating anxiety-like behaviors and HPA response in mice","volume":"65","author":"Chen","year":"2014","journal-title":"Horm Behav"},{"issue":"5","key":"2026050608273664900_ref21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.metabol.2005.01.008","article-title":"Glucocorticoids, depression, and mood disorders: structural remodeling in the brain","volume":"54","author":"McEwen","year":"2005","journal-title":"Metabolism."},{"issue":"8","key":"2026050608273664900_ref22","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/mp.2008.38","article-title":"Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances","volume":"13","author":"Wang","year":"2008","journal-title":"Mol Psychiatry"},{"issue":"2","key":"2026050608273664900_ref23","first-page":"264","article-title":"Androgen receptor locus on the human X chromosome: regional localization to Xq11-12 and description of a DNA polymorphism","volume":"44","author":"Brown","year":"1989","journal-title":"Am J Hum Genet"},{"issue":"6","key":"2026050608273664900_ref24","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/bies.20051","article-title":"The androgen receptor mRNA","volume":"26","author":"Yeap","year":"2004","journal-title":"BioEssays."},{"issue":"4","key":"2026050608273664900_ref25","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.genm.2012.05.001","article-title":"Testosterone levels and androgen receptor gene polymorphism predict specific symptoms of depression in young men","volume":"9","author":"Sankar","year":"2012","journal-title":"Gend Med"},{"issue":"2","key":"2026050608273664900_ref26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.yfrne.2007.10.005","article-title":"Non-genomic actions of androgens","volume":"29","author":"Foradori","year":"2008","journal-title":"Front Neuroendocrinol"},{"issue":"2","key":"2026050608273664900_ref27","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.maturitas.2009.03.008","article-title":"Mechanism of androgen receptor action","volume":"63","author":"Li","year":"2009","journal-title":"Maturitas."},{"issue":"9","key":"2026050608273664900_ref28","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/s41380-018-0198-y","article-title":"Sex-specific impact of prenatal androgens on social brain default mode subsystems","volume":"25","author":"Lombardo","year":"2020","journal-title":"Mol Psychiatry"},{"key":"2026050608273664900_ref29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bcp.2017.05.019","article-title":"Sex steroids and neurogenesis","volume":"141","author":"Heberden","year":"2017","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"2026050608273664900_ref30","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3390\/ph15101203","article-title":"Monoamine neurotransmitters control basic emotions and affect major depressive disorders","volume":"15","author":"Jiang","year":"2022","journal-title":"Pharmaceuticals."},{"issue":"4","key":"2026050608273664900_ref31","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1006\/hbeh.2002.1838","article-title":"Testosterone rapidly reduces anxiety in male house mice (Mus musculus)","volume":"42","author":"Aikey","year":"2002","journal-title":"Horm Behav"},{"key":"2026050608273664900_ref32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.psyneuen.2017.03.018","article-title":"Testosterone levels in healthy men correlate negatively with serotonin 4 receptor binding","volume":"81","author":"Perfalk","year":"2017","journal-title":"Psychoneuroendocrinology."},{"issue":"8","key":"2026050608273664900_ref33","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s00213-013-3415-z","article-title":"Impacts of stress and sex hormones on dopamine neurotransmission in the adolescent brain","volume":"231","author":"Sinclair","year":"2014","journal-title":"Psychopharmacology"},{"issue":"8","key":"2026050608273664900_ref34","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.biopsych.2014.09.010","article-title":"High-dose testosterone treatment increases serotonin transporter binding in transgender people","volume":"78","author":"Kranz","year":"2015","journal-title":"Biol Psychiatry"},{"issue":"2","key":"2026050608273664900_ref35","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.physbeh.2009.02.022","article-title":"Depression-like behavior of aged male and female mice is ameliorated with administration of testosterone or its metabolites","volume":"97","author":"Frye","year":"2009","journal-title":"Physiol Behav"},{"issue":"6","key":"2026050608273664900_ref36","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s11154-022-09767-0","article-title":"The role of testosterone, the androgen receptor, and hypothalamic-pituitary-gonadal axis in depression in ageing men","volume":"23","author":"Hauger","year":"2022","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"2026050608273664900_ref37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3109\/13685538.2015.1052392","article-title":"Age-related testosterone decline is due to waning of both testicular and hypothalamic-pituitary function","volume":"18","author":"Golan","year":"2015","journal-title":"Aging Male"},{"issue":"5","key":"2026050608273664900_ref38","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/ejendo\/lvae133","article-title":"Sociodemographic, lifes,tyle, and medical factors associated with calculated free testosterone concentrations in men: individual participant data meta-analyses","volume":"191","author":"Narinx","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2026050608273664900_ref39","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1001\/archpsyc.61.2.162","article-title":"Increased incidence of diagnosed depressive illness in hypogonadal older men","volume":"61","author":"Shores","year":"2004","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"2026050608273664900_ref40","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1111\/jsm.12937","article-title":"High rates of depression and depressive symptoms among men referred for borderline testosterone levels","volume":"12","author":"Westley","year":"2015","journal-title":"J Sex Med"},{"issue":"3","key":"2026050608273664900_ref41","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0306-4530(89)90020-6","article-title":"Neuroendocrine aspects of primary endogenous depression VIII. Pituitary-gonadal axis activity in male patients and matched control subjects","volume":"14","author":"Rubin","year":"1989","journal-title":"Psychoneuroendocrinology."},{"key":"2026050608273664900_ref42","doi-asserted-by":"publisher","first-page":"100792","DOI":"10.1016\/j.yfrne.2019.100792","article-title":"Hormones of the hypothalamic-pituitary-gonadal (HPG) axis in male depressive disorders\u2014a systematic review and meta-analysis","volume":"55","author":"Fischer","year":"2019","journal-title":"Front Neuroendocrinol"},{"issue":"11","key":"2026050608273664900_ref43","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1210\/js.2018-00137","article-title":"Depression in nonclassical hypogonadism in young men","volume":"2","author":"Korenman","year":"2018","journal-title":"J Endocr Soc"},{"key":"2026050608273664900_ref44","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fpsyt.2015.00061","article-title":"Serum testosterone levels and symptom-based depression subtypes in men","volume":"6","author":"Rodgers","year":"2015","journal-title":"Front Psychiatry"},{"issue":"3","key":"2026050608273664900_ref45","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/MED.0b013e3282fc27eb","article-title":"Testosterone and depression in men","volume":"15","author":"Amiaz","year":"2008","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"3","key":"2026050608273664900_ref46","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/00006842-199905000-00007","article-title":"Testosterone, gonadotr,opin, and cortisol secretion in male patients with major depression","volume":"61","author":"Schweiger","year":"1999","journal-title":"Psychosom Med"},{"issue":"1","key":"2026050608273664900_ref47","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/jamapsychiatry.2018.2734","article-title":"Association of Testosterone Treatment with alleviation of depressive symptoms in men: a systematic review and meta-analysis","volume":"76","author":"Walther","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"2026050608273664900_ref48","doi-asserted-by":"publisher","first-page":"e0177272","DOI":"10.1371\/journal.pone.0177272","article-title":"Associations of androgens with depressive symptoms and cognitive status in the general population","volume":"12","author":"Kische","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"2026050608273664900_ref49","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1192\/bjp.161.5.629","article-title":"Salivary testosterone levels and major depressive illness in men","volume":"161","author":"Davies","year":"1992","journal-title":"Br J Psychiatry"},{"issue":"8","key":"2026050608273664900_ref50","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3109\/08039488.2014.898791","article-title":"Saliva testosterone and cortisol in male depressive syndrome, a community study. The Sudurnesjamenn Study","volume":"68","author":"Sigurdsson","year":"2014","journal-title":"Nord J Psychiatry"},{"issue":"7","key":"2026050608273664900_ref51","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1210\/jc.2005-0212","article-title":"Androgen levels in adult females: changes with age, menopause, and oophorectomy","volume":"90","author":"Davison","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2026050608273664900_ref52","doi-asserted-by":"publisher","first-page":"107822","DOI":"10.1016\/j.maturitas.2023.107822","article-title":"Associations between low sex hormone concentrations and depression in older women: an observational study","volume":"176","author":"Islam","year":"2023","journal-title":"Maturitas"},{"issue":"Suppl 3","key":"2026050608273664900_ref53","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1743-6109.2007.00448.x","article-title":"Hormonal changes in menopause and implications on sexual health","volume":"4","author":"Schwenkhagen","year":"2007","journal-title":"J Sex Med"},{"issue":"10","key":"2026050608273664900_ref54","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1056\/NEJM200009073431002","article-title":"Transdermal testosterone treatment in women with impaired sexual function after oophorectomy","volume":"343","author":"Shifren","year":"2000","journal-title":"N Engl J Med"},{"key":"2026050608273664900_ref55","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.maturitas.2022.11.001","article-title":"The association between testosterone and depression in postmenopausal women: a systematic review of observational studies","volume":"168","author":"Hemachandra","year":"2023","journal-title":"Maturitas."},{"issue":"11","key":"2026050608273664900_ref56","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1210\/jcem.84.11.6153","article-title":"The effect of deydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life","volume":"84","author":"Barnhart","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2026050608273664900_ref57","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jad.2014.04.068","article-title":"Association of testosterone levels and future suicide attempts in females with bipolar disorder","volume":"166","author":"Sher","year":"2014","journal-title":"J Affect Disord"},{"issue":"12","key":"2026050608273664900_ref58","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/S2213-8587(15)00284-3","article-title":"Testosterone in women\u2014the clinical significance","volume":"3","author":"Davis","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2026050608273664900_ref59","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13293-020-00319-2","article-title":"Roles for androgens in mediating the sex differences of neuroendocrine and behavioral stress responses","volume":"11","author":"Zuloaga","year":"2020","journal-title":"Biol Sex Differ"},{"issue":"2","key":"2026050608273664900_ref60","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0888-7543(92)90371-X","article-title":"Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups","volume":"12","author":"Edwards","year":"1992","journal-title":"Genomics."},{"issue":"8-10","key":"2026050608273664900_ref61","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.psyneuen.2007.06.014","article-title":"Total testosterone, androgen receptor polymorphism, and depressive symptoms in young black and white men: the CARDIA Male Hormone Study","volume":"32","author":"Colangelo","year":"2007","journal-title":"Psychoneuroendocrinology."},{"issue":"8","key":"2026050608273664900_ref62","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1053\/meta.2000.7710","article-title":"Testosterone and leptin in older African-American men: relationship to age, strength, function, and season","volume":"49","author":"Perry","year":"2000","journal-title":"Metabolism."},{"issue":"6","key":"2026050608273664900_ref63","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1111\/j.1743-6109.2012.02709.x","article-title":"Bidirectional association between depression and sexual dysfunction: a systematic review and meta-analysis","volume":"9","author":"Atlantis","year":"2012","journal-title":"J Sex Med"},{"issue":"5","key":"2026050608273664900_ref64","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1097\/AOG.0b013e3181898cdb","article-title":"Sexual problems and distress in United States women: prevalence and correlates","volume":"112","author":"Shifren","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"8","key":"2026050608273664900_ref65","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jsxm.2018.05.016","article-title":"Erectile dysfunction and depression: a systematic review and meta-analysis","volume":"15","author":"Liu","year":"2018","journal-title":"J Sex Med"},{"issue":"5","key":"2026050608273664900_ref66","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S0090-4295(98)00292-1","article-title":"Increased incidence of depressive symptoms in men with erectile dysfunction","volume":"52","author":"Shabsigh","year":"1998","journal-title":"Urology."},{"issue":"6","key":"2026050608273664900_ref67","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s11154-022-09748-3","article-title":"The role of testosterone in male sexual function","volume":"23","author":"Corona","year":"2022","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"2026050608273664900_ref68","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s43440-022-00444-2","article-title":"Estrogen fluctuations during the menopausal transition are a risk factor for depressive disorders","volume":"75","author":"Turek","year":"2023","journal-title":"Pharmacol Rep"},{"issue":"10","key":"2026050608273664900_ref69","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1007\/s00213-019-05326-9","article-title":"Stress, sex hormones, inflammation, and major depressive disorder: extending social signal transduction theory of depression to account for sex differences in mood disorders","volume":"236","author":"Slavich","year":"2019","journal-title":"Psychopharmacology"},{"issue":"5","key":"2026050608273664900_ref70","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1210\/jc.2018-00404","article-title":"The efficacy and adverse events of testosterone replacement therapy in hypogonadal men: a systematic review and meta-analysis of randomized, placebo-controlled trials","volume":"103","author":"Ponce","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026050608273664900_ref71","doi-asserted-by":"publisher","first-page":"e015284","DOI":"10.1136\/bmjopen-2016-015284","article-title":"Testosterone therapy in hypogonadal men: a systematic review and network meta-analysis","volume":"7","author":"Elliott","year":"2017","journal-title":"BMJ Open"},{"issue":"1","key":"2026050608273664900_ref72","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/00004714-199902000-00006","article-title":"Testosterone therapy for human immunodeficiency virus-positive men with and without hypogonadism","volume":"19","author":"Rabkin","year":"1999","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"2026050608273664900_ref73","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/01.jcp.0000132442.35478.3c","article-title":"Testosterone versus fluoxetine for depression and fatigue in HIV\/AIDS: a placebo-controlled trial","volume":"24","author":"Rabkin","year":"2004","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"2026050608273664900_ref74","doi-asserted-by":"publisher","first-page":"406","DOI":"10.4088\/JCP.v62n0602","article-title":"Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial","volume":"62","author":"Seidman","year":"2001","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"2026050608273664900_ref75","doi-asserted-by":"publisher","first-page":"834","DOI":"10.21037\/tau.2016.07.10","article-title":"Pharmacology of testosterone replacement therapy preparations","volume":"5","author":"Shoskes","year":"2016","journal-title":"Transl Androl Urol"},{"issue":"9","key":"2026050608273664900_ref76","doi-asserted-by":"publisher","first-page":"e0162480","DOI":"10.1371\/journal.pone.0162480","article-title":"Treatment of men for \u201clow testosterone\u201d: a systematic review","volume":"11","author":"Huo","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"2026050608273664900_ref77","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1176\/appi.ajp.160.1.105","article-title":"Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial","volume":"160","author":"Pope","year":"2003","journal-title":"Am J Psychiatry"},{"issue":"5","key":"2026050608273664900_ref78","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/01.GME.0000060256.03945.20","article-title":"Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women","volume":"10","author":"Goldstat","year":"2003","journal-title":"Menopause."},{"issue":"12","key":"2026050608273664900_ref79","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1017\/S1092852900023944","article-title":"Low-dose transdermal testosterone augmentation therapy improves depression severity in women","volume":"14","author":"Miller","year":"2009","journal-title":"CNS Spectr"},{"issue":"10","key":"2026050608273664900_ref80","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1176\/appi.ajp.2020.19080844","article-title":"Low-dose testosterone augmentation for antidepressant-resistant major depressive disorder in women: an 8-week randomized placebo-controlled study","volume":"177","author":"Dichtel","year":"2020","journal-title":"Am J Psychiatry"},{"issue":"3","key":"2026050608273664900_ref81","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00737-024-01513-6","article-title":"Effect of transdermal testosterone therapy on mood and cognitive symptoms in peri- and postmenopausal women: a pilot study","volume":"28","author":"Glynne","year":"2025","journal-title":"Arch Womens Ment Health"},{"issue":"10","key":"2026050608273664900_ref82","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1210\/jc.2019-01603","article-title":"Global consensus position statement on the use of testosterone therapy for women","volume":"104","author":"Davis","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026050608273664900_ref83","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa2215025","article-title":"Cardiovascular safety of testosterone-replacement therapy","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"12","key":"2026050608273664900_ref84","doi-asserted-by":"publisher","first-page":"e2348692","DOI":"10.1001\/jamanetworkopen.2023.48692","article-title":"Prostate safety events during testosterone replacement therapy in men with hypogonadism: a randomized clinical trial","volume":"6","author":"Bhasin","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"9","key":"2026050608273664900_ref85","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/j.1464-410X.2008.08240.x","article-title":"Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy","volume":"103","author":"Coward","year":"2009","journal-title":"BJU Int"},{"key":"2026050608273664900_ref86","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.euros.2024.01.005","article-title":"Oncologic outcomes of testosterone therapy for men on active surveillance for prostate cancer: a population-based analysis","volume":"60","author":"Kaplan-Marans","year":"2024","journal-title":"Eur Urol Open Sci"},{"issue":"2","key":"2026050608273664900_ref87","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.urology.2013.03.049","article-title":"Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes","volume":"82","author":"Kaplan","year":"2013","journal-title":"Urology."},{"issue":"2","key":"2026050608273664900_ref88","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.juro.2013.02.002","article-title":"Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy","volume":"190","author":"Pastuszak","year":"2013","journal-title":"J Urol"},{"issue":"8","key":"2026050608273664900_ref89","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.urolonc.2020.04.008","article-title":"Testosterone replacement therapy (TRT) and prostate cancer: an updated systematic review with a focus on previous or active localized prostate cancer","volume":"38","author":"Lenfant","year":"2020","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"4","key":"2026050608273664900_ref90","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00345-013-1187-z","article-title":"Lower urinary tract symptoms improve with testosterone replacement therapy in men with late-onset hypogonadism: 5-year prospective, observational and longitudinal registry study","volume":"32","author":"Yassin","year":"2014","journal-title":"World J Urol"},{"issue":"5","key":"2026050608273664900_ref91","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/j.juro.2013.05.111","article-title":"Testosterone supplementation does not worsen lower urinary tract symptoms","volume":"190","author":"Pearl","year":"2013","journal-title":"J Urol"},{"issue":"4","key":"2026050608273664900_ref92","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2265.2012.04413.x","article-title":"Effects of testosterone therapy on sleep and breathing in obese men with severe obstructive sleep apnoea: a randomized placebo-controlled trial","volume":"77","author":"Hoyos","year":"2012","journal-title":"Clin Endocrinol"},{"issue":"1","key":"2026050608273664900_ref93","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.2047-2927.2012.00009.x","article-title":"Is the haematopoietic effect of testosterone mediated by erythropoietin? The results of a clinical trial in older men","volume":"1","author":"Maggio","year":"2013","journal-title":"Andrology."},{"issue":"3","key":"2026050608273664900_ref94","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1210\/jc.2007-1692","article-title":"Effects of graded doses of testosterone on erythropoiesis in healthy young and older men","volume":"93","author":"Coviello","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026050608273664900_ref95","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S2213-8587(19)30189-5","article-title":"Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data","volume":"7","author":"Islam","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2026050608273664900_ref96","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.juro.2018.03.115","article-title":"Evaluation and management of testosterone deficiency: AUA guideline","volume":"200","author":"Mulhall","year":"2018","journal-title":"J Urol"}],"container-title":["Sexual Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/smr\/article-pdf\/14\/2\/qeag024\/68226601\/qeag024.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/smr\/article-pdf\/14\/2\/qeag024\/68226601\/qeag024.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:27:43Z","timestamp":1778070463000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/smr\/article\/doi\/10.1093\/sxmrev\/qeag024\/8670397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":96,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/sxmrev\/qeag024","relation":{},"ISSN":["2050-0513","2050-0521"],"issn-type":[{"value":"2050-0513","type":"print"},{"value":"2050-0521","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,4,1]]},"article-number":"qeag024"}}